Safety and Efficacy of Vagus Nerve Stimulator in Patients With Rheumatoid Arthritis (RA)

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 6, 2018

Primary Completion Date

December 10, 2018

Study Completion Date

December 10, 2018

Conditions

Rheumatoid Arthritis

Interventions

DEVICE

SetPoint Medical Neurostimulation of the Cholinergic Anti-inflammatory Pathway System

Active Implantable Vagus Nerve Stimulation device.

Trial Locations (4)

Northwell Health Division of Rheumatology, Great Neck

Altoona Center for Clinical Research, Duncansville

Arthritis & Rheumatic Disease Specialties, Aventura

Florida Medical Clinic, P.A., Zephyrhills

All Listed Sponsors

lead

SetPoint Medical Corporation

INDUSTRY

NCT03437473 - Safety and Efficacy of Vagus Nerve Stimulator in Patients With Rheumatoid Arthritis (RA) | Biotech Hunter | Biotech Hunter